BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17220331)

  • 1. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.
    Bean GR; Ibarra Drendall C; Goldenberg VK; Baker JC; Troch MM; Paisie C; Wilke LG; Yee L; Marcom PK; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Scott V; Seewaldt VL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):50-6. PubMed ID: 17220331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
    Bean GR; Bryson AD; Pilie PG; Goldenberg V; Baker JC; Ibarra C; Brander DM; Paisie C; Case NR; Gauthier M; Reynolds PA; Dietze E; Ostrander J; Scott V; Wilke LG; Yee L; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Tlsty TD; Seewaldt VL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6834-41. PubMed ID: 18006786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration.
    Bean GR; Scott V; Yee L; Ratliff-Daniel B; Troch MM; Seo P; Bowie ML; Marcom PK; Slade J; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Baker JC; Wilke LG; Seewaldt VL
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):790-8. PubMed ID: 15824145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
    Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
    Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
    Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
    Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the BRCA1 gene in sporadic breast cancer.
    Dobrovic A; Simpfendorfer D
    Cancer Res; 1997 Aug; 57(16):3347-50. PubMed ID: 9269993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.
    Lewis CM; Cler LR; Bu DW; Zöchbauer-Müller S; Milchgrub S; Naftalis EZ; Leitch AM; Minna JD; Euhus DM
    Clin Cancer Res; 2005 Jan; 11(1):166-72. PubMed ID: 15671542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
    Goldenberg VK; Seewaldt VL; Scott V; Bean GR; Broadwater G; Fabian C; Kimler B; Zalles C; Lipkus IM
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1032-4. PubMed ID: 17507634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.
    Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
    Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
    Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cytology and biomarkers obtained by random fine needle aspiration: use in risk assessment and early chemoprevention trials.
    Fabian CJ; Zalles C; Kamel S; Zeiger S; Simon C; Kimler BF
    J Cell Biochem Suppl; 1997; 28-29():101-10. PubMed ID: 9589354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
    Baldwin RL; Nemeth E; Tran H; Shvartsman H; Cass I; Narod S; Karlan BY
    Cancer Res; 2000 Oct; 60(19):5329-33. PubMed ID: 11034065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
    Arun B; Valero V; Logan C; Broglio K; Rivera E; Brewster A; Yin G; Green M; Kuerer H; Gong Y; Browne D; Hortobagyi GN; Sneige N
    Clin Cancer Res; 2007 Aug; 13(16):4943-8. PubMed ID: 17699874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens.
    Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ
    Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.